Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

555 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immunogenicity and protective capacity.
Meyer Zu Natrup C, Tscherne A, Dahlke C, Ciurkiewicz M, Shin DL, Fathi A, Rohde C, Kalodimou G, Halwe S, Limpinsel L, Schwarz JH, Klug M, Esen M, Schneiderhan-Marra N, Dulovic A, Kupke A, Brosinski K, Clever S, Schünemann LM, Beythien G, Armando F, Mayer L, Weskamm ML, Jany S, Freudenstein A, Tuchel T, Baumgärtner W, Kremsner P, Fendel R, Addo MM, Becker S, Sutter G, Volz A. Meyer Zu Natrup C, et al. Among authors: fathi a. J Clin Invest. 2022 Dec 15;132(24):e159895. doi: 10.1172/JCI159895. J Clin Invest. 2022. PMID: 36301637 Free PMC article.
Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial.
Koch T, Dahlke C, Fathi A, Kupke A, Krähling V, Okba NMA, Halwe S, Rohde C, Eickmann M, Volz A, Hesterkamp T, Jambrecina A, Borregaard S, Ly ML, Zinser ME, Bartels E, Poetsch JSH, Neumann R, Fux R, Schmiedel S, Lohse AW, Haagmans BL, Sutter G, Becker S, Addo MM. Koch T, et al. Among authors: fathi a. Lancet Infect Dis. 2020 Jul;20(7):827-838. doi: 10.1016/S1473-3099(20)30248-6. Epub 2020 Apr 21. Lancet Infect Dis. 2020. PMID: 32325037 Free PMC article. Clinical Trial.
[Less is more… in infectious diseases].
Fathi A, Hennigs A, Addo MM. Fathi A, et al. Internist (Berl). 2021 Apr;62(4):373-378. doi: 10.1007/s00108-021-00967-5. Epub 2021 Feb 12. Internist (Berl). 2021. PMID: 33580310 Review. German.
Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, Dahlke C, Kobbe R, Santer R, Koch T, Fathi A, Seco BMS, Ly ML, Schmiedel S, Schwinge D, Serna S, Sellrie K, Reichardt NC, Seeberger PH, Addo MM, Loeffler FF, On Behalf Of The Id-Uke Covid-Study Group. Heidepriem J, et al. Among authors: fathi a. Pathogens. 2021 Apr 6;10(4):438. doi: 10.3390/pathogens10040438. Pathogens. 2021. PMID: 33917609 Free PMC article.
The COVID-19 Vaccine Landscape.
Koch T, Fathi A, Addo MM. Koch T, et al. Among authors: fathi a. Adv Exp Med Biol. 2021;1318:549-573. doi: 10.1007/978-3-030-63761-3_31. Adv Exp Med Biol. 2021. PMID: 33973199 Review.
Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.
Velavan TP, Kuk S, Linh LTK, Lamsfus Calle C, Lalremruata A, Pallerla SR, Kreidenweiss A, Held J, Esen M, Gabor J, Neurohr EM, Shamsrizi P, Fathi A, Biecker E, Berg CP, Ramharter M, Addo MM, Kreuels B, Kremsner PG. Velavan TP, et al. Among authors: fathi a. Sci Rep. 2021 Jul 14;11(1):14471. doi: 10.1038/s41598-021-93950-x. Sci Rep. 2021. PMID: 34262116 Free PMC article.
555 results